Over the past 12 months, 0 insiders at CASI Pharmaceuticals, Inc. filed 0 open-market SEC Form 4 transactions on CASI: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 22 | James HuangDirector | BUY | 33.3K | $4.28 | $143K |
| Sep 7, 22 | James HuangDirector | BUY | 3.1K | $4.00 | $12K |
| Sep 6, 22 | James HuangDirector | BUY | 19.2K | $3.89 | $75K |
| Sep 2, 22 | James HuangDirector | BUY | 400 | $3.74 | $1K |
| Sep 1, 22 | James HuangDirector | BUY | 11.8K | $3.72 | $44K |
| Aug 31, 22 | James HuangDirector | BUY | 25.0K | $3.75 | $94K |
| Aug 26, 22 | James HuangDirector | BUY | 39.5K | $3.75 | $148K |
| Aug 24, 22 | James HuangDirector | BUY | 5.0K | $3.75 | $19K |
| Aug 23, 22 | James HuangDirector | BUY | 40.0K | $3.50 | $140K |
| Aug 22, 22 | James HuangDirector | BUY | 23.1K | $3.46 | $80K |
| Aug 19, 22 | James HuangDirector | BUY | 171.1K | $3.27 | $560K |
| Jun 15, 22 | Wei-wu HeChairman and CEO | BUY | 50.0K | $3.18 | $159K |
| Jun 14, 22 | Wei-wu HeChairman and CEO | BUY | 2.1K | $3.06 | $6K |
| Jun 13, 22 | Wei-wu HeChairman and CEO | BUY | 36.1K | $2.97 | $107K |
| Nov 18, 21 | Wei-wu HeChairman and CEO | BUY | 200.0K | $0.98 | $196K |
| Nov 17, 21 | Wei-wu HeChairman and CEO | BUY | 200.0K | $0.99 | $198K |
| Aug 19, 21 | Wei-wu HeChairman and CEO | BUY | 180.0K | $1.26 | $227K |
| Aug 18, 21 | Wei-wu HeChairman and CEO | BUY | 300.0K | $1.29 | $387K |
Over the past 12 months, insiders at CASI Pharmaceuticals, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on CASI, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market CASI insider purchase in our data was $560K by James Huang, Director, filed on Aug 19, 22.
0 different insiders at CASI Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on CASI over the last 12 months.
InsiderTape plots every CASI insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every CASI Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →